The two researchers who created the technique that resulted in the mRNA Covid vaccinations received the Nobel Prize in Physiology or Medicine. Drew Weissman and Katalin Kariko, both professors, will split the award. Prior to the pandemic, the technology was in its experimental stage, but it has since distributed to millions of individuals worldwide to provide them with substantial Covid-19 protection.
Currently, the same mRNA technology is being studied for a variety of illnesses, including cancer. According to the Nobel Prize committee, “the laureates contributed to the unprecedented rate of vaccine development during one of the greatest threats to human health in modern times.” Both reportedly “overwhelmed” when they received the good news via phone this morning. Immune systems trained to recognize and combat dangers like viruses and bacteria via vaccinations.
The foundation of conventional vaccine technology has been the use of pieces of the infectious agent or dead or weakened forms of the original virus or bacteria. Covid will “continue to surprise us,” it advised.
Messenger ribonucleic acid (mRNA) vaccines, on the other hand, take an entirely different strategy. Both the Moderna and Pfizer/BioNTech vaccines used mRNA technology during the Covid pandemic.
When they both working at the University of Pennsylvania in the United States in the early 1990s and their interest in mRNA seen as a scientific niche, Professors Kariko and Weissman met. The genetic blueprints for creating one coronavirus component—a protein— found in an mRNA Covid vaccination. Injection of this causes our cells to produce large amounts of the viral protein. The immune system recognizes them as alien, assaults, and learns how to combat the virus. As a result, it will better prepared to fend off infections in the future.
Also Read:- Indian Cricket Stars Join PM Modi’s ‘Clean India’ Campaign
